Dissolving microneedles developed in association with nanosystems : a scoping review on the quality parameters of these emerging systems for drug or protein transdermal delivery
Main Author: | |
---|---|
Publication Date: | 2021 |
Other Authors: | , |
Format: | Article |
Language: | eng |
Source: | Repositório Institucional da UFRGS |
Download full: | http://hdl.handle.net/10183/249600 |
Summary: | The largest organ of the body provides the main challenge for the transdermal delivery of lipophilic or high molecular weight drugs. To cross the main barrier of the skin, the stratum corneum, many techniques have been developed and improved. In the last 20 years, the association of microneedles with nanostructured systems has gained prominence for its versatility and for enabling targeted drug delivery. Currently, the combination of these mechanisms is pointed to as an emerging technology; however, some gaps need to be answered to transcend the development of these devices from the laboratory scale to the pharmaceutical market. It is known that the lack of regulatory guidelines for quality control is a hindrance to market conquest. In this context, this study undertakes a scoping review of original papers concerning methods applied to evaluate both the quality and drug/protein delivery of dissolving and hydrogel-forming microneedles developed in association with nanostructured systems. |
id |
UFRGS-2_7de16e706cea3cf0787bc88c2f35e2c0 |
---|---|
oai_identifier_str |
oai:www.lume.ufrgs.br:10183/249600 |
network_acronym_str |
UFRGS-2 |
network_name_str |
Repositório Institucional da UFRGS |
repository_id_str |
|
spelling |
Weimer, PatríciaRossi, Rochele CassantaKoester, Leticia Scherer2022-10-03T04:48:55Z20211999-4923http://hdl.handle.net/10183/249600001149355The largest organ of the body provides the main challenge for the transdermal delivery of lipophilic or high molecular weight drugs. To cross the main barrier of the skin, the stratum corneum, many techniques have been developed and improved. In the last 20 years, the association of microneedles with nanostructured systems has gained prominence for its versatility and for enabling targeted drug delivery. Currently, the combination of these mechanisms is pointed to as an emerging technology; however, some gaps need to be answered to transcend the development of these devices from the laboratory scale to the pharmaceutical market. It is known that the lack of regulatory guidelines for quality control is a hindrance to market conquest. In this context, this study undertakes a scoping review of original papers concerning methods applied to evaluate both the quality and drug/protein delivery of dissolving and hydrogel-forming microneedles developed in association with nanostructured systems.application/pdfengPharmaceutics. Basel. Vol. 13, n. 10 (2021), 1601, 28 p.Pele : MedicamentosControle de qualidadeNanotecnologiaMicroarray patchDissolving microneedlesHydrogel-forming microneedlesNanostructured systemsNanoparticlesTransdermal deliveryTranscutaneous immunizationSkin permeationSkin depositionQuality controlDissolving microneedles developed in association with nanosystems : a scoping review on the quality parameters of these emerging systems for drug or protein transdermal deliveryEstrangeiroinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT001149355.pdf.txt001149355.pdf.txtExtracted Texttext/plain106013http://www.lume.ufrgs.br/bitstream/10183/249600/2/001149355.pdf.txtb5a768fc8bf66ff1e8b51b5754a8fb28MD52ORIGINAL001149355.pdfTexto completo (inglês)application/pdf1440975http://www.lume.ufrgs.br/bitstream/10183/249600/1/001149355.pdf6e99191c0597cfe2d00a1272611b6814MD5110183/2496002022-10-04 05:01:10.239566oai:www.lume.ufrgs.br:10183/249600Repositório InstitucionalPUBhttps://lume.ufrgs.br/oai/requestlume@ufrgs.bropendoar:2022-10-04T08:01:10Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false |
dc.title.pt_BR.fl_str_mv |
Dissolving microneedles developed in association with nanosystems : a scoping review on the quality parameters of these emerging systems for drug or protein transdermal delivery |
title |
Dissolving microneedles developed in association with nanosystems : a scoping review on the quality parameters of these emerging systems for drug or protein transdermal delivery |
spellingShingle |
Dissolving microneedles developed in association with nanosystems : a scoping review on the quality parameters of these emerging systems for drug or protein transdermal delivery Weimer, Patrícia Pele : Medicamentos Controle de qualidade Nanotecnologia Microarray patch Dissolving microneedles Hydrogel-forming microneedles Nanostructured systems Nanoparticles Transdermal delivery Transcutaneous immunization Skin permeation Skin deposition Quality control |
title_short |
Dissolving microneedles developed in association with nanosystems : a scoping review on the quality parameters of these emerging systems for drug or protein transdermal delivery |
title_full |
Dissolving microneedles developed in association with nanosystems : a scoping review on the quality parameters of these emerging systems for drug or protein transdermal delivery |
title_fullStr |
Dissolving microneedles developed in association with nanosystems : a scoping review on the quality parameters of these emerging systems for drug or protein transdermal delivery |
title_full_unstemmed |
Dissolving microneedles developed in association with nanosystems : a scoping review on the quality parameters of these emerging systems for drug or protein transdermal delivery |
title_sort |
Dissolving microneedles developed in association with nanosystems : a scoping review on the quality parameters of these emerging systems for drug or protein transdermal delivery |
author |
Weimer, Patrícia |
author_facet |
Weimer, Patrícia Rossi, Rochele Cassanta Koester, Leticia Scherer |
author_role |
author |
author2 |
Rossi, Rochele Cassanta Koester, Leticia Scherer |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Weimer, Patrícia Rossi, Rochele Cassanta Koester, Leticia Scherer |
dc.subject.por.fl_str_mv |
Pele : Medicamentos Controle de qualidade Nanotecnologia |
topic |
Pele : Medicamentos Controle de qualidade Nanotecnologia Microarray patch Dissolving microneedles Hydrogel-forming microneedles Nanostructured systems Nanoparticles Transdermal delivery Transcutaneous immunization Skin permeation Skin deposition Quality control |
dc.subject.eng.fl_str_mv |
Microarray patch Dissolving microneedles Hydrogel-forming microneedles Nanostructured systems Nanoparticles Transdermal delivery Transcutaneous immunization Skin permeation Skin deposition Quality control |
description |
The largest organ of the body provides the main challenge for the transdermal delivery of lipophilic or high molecular weight drugs. To cross the main barrier of the skin, the stratum corneum, many techniques have been developed and improved. In the last 20 years, the association of microneedles with nanostructured systems has gained prominence for its versatility and for enabling targeted drug delivery. Currently, the combination of these mechanisms is pointed to as an emerging technology; however, some gaps need to be answered to transcend the development of these devices from the laboratory scale to the pharmaceutical market. It is known that the lack of regulatory guidelines for quality control is a hindrance to market conquest. In this context, this study undertakes a scoping review of original papers concerning methods applied to evaluate both the quality and drug/protein delivery of dissolving and hydrogel-forming microneedles developed in association with nanostructured systems. |
publishDate |
2021 |
dc.date.issued.fl_str_mv |
2021 |
dc.date.accessioned.fl_str_mv |
2022-10-03T04:48:55Z |
dc.type.driver.fl_str_mv |
Estrangeiro info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10183/249600 |
dc.identifier.issn.pt_BR.fl_str_mv |
1999-4923 |
dc.identifier.nrb.pt_BR.fl_str_mv |
001149355 |
identifier_str_mv |
1999-4923 001149355 |
url |
http://hdl.handle.net/10183/249600 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartof.pt_BR.fl_str_mv |
Pharmaceutics. Basel. Vol. 13, n. 10 (2021), 1601, 28 p. |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFRGS instname:Universidade Federal do Rio Grande do Sul (UFRGS) instacron:UFRGS |
instname_str |
Universidade Federal do Rio Grande do Sul (UFRGS) |
instacron_str |
UFRGS |
institution |
UFRGS |
reponame_str |
Repositório Institucional da UFRGS |
collection |
Repositório Institucional da UFRGS |
bitstream.url.fl_str_mv |
http://www.lume.ufrgs.br/bitstream/10183/249600/2/001149355.pdf.txt http://www.lume.ufrgs.br/bitstream/10183/249600/1/001149355.pdf |
bitstream.checksum.fl_str_mv |
b5a768fc8bf66ff1e8b51b5754a8fb28 6e99191c0597cfe2d00a1272611b6814 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS) |
repository.mail.fl_str_mv |
lume@ufrgs.br |
_version_ |
1834472552393605120 |